BIOCONTROL TECHNOLOGY, INC.
2275 Swallow Hill Road - Building 2500 - Pittsburgh, PA 15220
(412) 429-0673 Fax: (412) 279-1367
BIOCONTROL TO BEGIN IN-HOME TESTING WITH DIASENSOR 1000TM
Pittsburgh, PA - January 23, 1997 - Biocontrol Technology, Inc. (NASDAQ:BICO) announced today that an in-home study of the Diasensor 1000TM noninvasive glucose sensor will begin February 3, 1997 as the various issues concerning the study protocol have been addressed with the Food and Drug Administration (FDA).
Although there can be no guarantees, the Company anticipates that the study will take approximately 120 days to complete. Once the study is completed, the Company will resubmit its 510(k) application with the new data to the FDA for approval to market the Diasensor 1000 in the United States.
The Company also stated that further details of the study will remain confidential at this time.
Without the need to finger prick as current monitors require, the Diasensor 1000 measures blood glucose levels using near infrared technology.
Biocontrol Technology, Inc. has its corporate offices in Pittsburgh, PA and is involved in the development and manufacture of biomedical devices and environmental products.
Last Updated: Thursday August 29, 2002 20:59:48
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2014. Comments and Feedback.